Market Tracker

07/29 6:05pm ET

Dynavax Technologies Corp (NASDAQ:DVAX)

1.46
Data as of Jul 29
 +0.087 / +6.35%
Today’s Change
1.10
Today|||52-Week Range
2.14
-25.66%
Year-to-Date
No recent news for Dynavax Technologies Corp.

Today’s Trading

Previous close1.37
Today’s open1.37
Day’s range1.37 - 1.48
Volume6,967,796
Average volume (3 months)2,029,446
Market cap$360.1M
Dividend yield--
Data as of 4:00pm ET, 07/29/2014

Growth & Valuation

Earnings growth (last year)+7.32%
Earnings growth (this year)+34.21%
Earnings growth (next 5 years)--
Revenue growth (last year)+15.82%
P/E ratioNM
Price/Sales34.19
Price/Book1.93

Competitors

 Today’s
change
Today’s
% change
PETXAratana Therapeutics...-0.09-0.73%
NWBONorthwest Biotherape...+0.29+4.57%
DRTXDurata Therapeutics ...-0.55-4.12%
PGNXProgenics Pharmaceut...+0.04+0.80%
Data as of 3:59pm ET, 07/29/2014

Financials

Next reporting dateAugust 5, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$11.3M
Annual profit (last year)-$66.7M
Net profit margin-593.01%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts